April 23, 2012
Eisai Co., Ltd. revealed on April 20 that Teikoku Pharma USA (TPU), a US subsidiary of Teikoku Seiyaku Co., Ltd., which is developing a once-weekly transdermal patch for Aricept (donepezil) for Alzheimer’s disease, has withdrawn its new drug application (NDA)...read more